The field of cancer biology has witnessed rapid advances in our understanding of microRNAs (miRNAs) as crucial regulators of ...
MicroRNAs, whose discovery was recognized with the 2025 Nobel Prize in Physiology or Medicine, are central regulators of gene ...
Researchers have discovered novel biomarkers that could allow doctors to detect endometriosis in its earliest stages through ...
Background: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors with variable behavior and metastatic potential. Reliable prognostic biomarkers are needed to improve risk ...
Background/aims Pseudoexfoliation syndrome (PXS) is associated with increased risk of glaucoma, but the underlying molecular mechanisms remain unclear. This study aimed to compare microRNA (miRNA) ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Postmenopausal osteoporosis generally occurs within 5–10 years ...
Abstract: This study aimed to investigate aberrant microRNA (miRNA) expression in colon cancer using a bioinformatics pipeline. miRNA expression and clinical data were retrieved from the National ...
The global miRNA sequencing and assay market size to grow from US$ 391.73 million in 2024, rise to US$ 443.95 million in 2025, and is expected to surpass US$ 1369.11 million by 2034. The market is ...
Celyad Oncology (Euronext: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), today announces the publication of the preclinical data of the non-gene edited allogeneic CYAD-211 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback